Ascentage Pharma Group In... (AAPG)
20.88
2.18 (11.66%)
At close: Apr 14, 2025, 3:59 PM
20.21
-3.21%
After-hours: Apr 14, 2025, 07:54 PM EDT
11.66% (1D)
| Bid | 19.6 |
| Market Cap | 1.81B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.73 |
| PE Ratio (ttm) | -28.6 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 20.65 |
| Volume | 14,900 |
| Avg. Volume (20D) | 122,018 |
| Open | 19.33 |
| Previous Close | 18.70 |
| Day's Range | 19.29 - 20.88 |
| 52-Week Range | 16.50 - 24.02 |
| Beta | 1.00 |
About AAPG
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibitor for hematologic malignancies and solid tumors; A...
Industry Biotechnology
Sector Healthcare
IPO Date Jan 24, 2025
Employees 567
Stock Exchange NASDAQ
Ticker Symbol AAPG
Website https://www.ascentage.cn
2 weeks ago
+9.96%
Ascentage Pharma Group shares are trading higher a...
Unlock content with
Pro Subscription
